Skip to main content
. 2018 Apr 20;9(30):21141–21155. doi: 10.18632/oncotarget.24975

Figure 7. Prostaglandin E2 mediates sensitivity to T-DM1 in resistant cells.

Figure 7

(A) The expression of genes involved in the prostaglandin pathway is highly modified in resistant cells to T-DM1. The results shown are the expression fold changes of TR or TCR over parental cells for the indicated genes determined by RT-qPCR. (B) Sensitivity to aspirin studied by MTT assay was found to be increased in TR and TCR cells compared to S cells (*: P<0,05; **: P<0,01). (C) Quantification by ELISA of PGE2 in the supernatant of each cell line shows an increased amount in TR cells compared to parental cells. (D) Wound healing assay performed on OE-19 S, TR and TCR cell lines in the absence or presence of 10 μM PGE2. The addition of PGE2 decreased the migration speed of the parental cell line but had no effect on the migration speed of both resistant cell lines. (E) Cell survival after exposure to 1 nM T-DM1 and 10 μM PGE2 was studied by Annexin V/PI staining after 72h exposure. The presence of PGE2 increases the sensitivity to T-DM1 of resistant models. (F) The increased sensitivity to T-DM1 in the presence of PGE2 was confirmed by xCELLigence. After overnight incubation cells were exposed to 1 μM PGE2 and/or 0,1 nM T-DM1. The normalized cell index of TR and TCR cells exposed to T-DM1 and PGE2 is inferior to control, PGE2 and T-DM1.A single experiment is shown, representative of 3 experiments.